Add to ORKGUS10231897; US10231897 B2; US10231897B2; US10,231,897; US10,231,897 B2; 10231897; Appl. No. 15/837,907US202006 bcrcVersion of Recor
Inventor name used in this publication: 谢欣然Inventor name used in this publication: 杜嗣河Inventor name ...
A lens includes a center of the ophthalmic lens having a negative power that provides foveal vision ...
Amblyopia is defined as a decrease in visual acuity that results from abnormal binocular interaction...
US9918894B2; US9918894 B2; US9918894B2; US9,918,894; US9918894 B2; 9918894; Appl. No. 15/009,224US20...
US9829722; US9829722 B2; US9829722B2; US9,829,722; US 9,829,722 B2; 9829722; Appl. No. 14/581,003US2...
US9557099; US9557099 B2; US9557099B2; US9,557,099; US 9,557,099 B2; 9557099; Appl. No. 14/261,868US2...
A method for retarding the progression of myopia in a human eye is provided. The method comprises pr...
US9089288; US9089288 B2; US9089288B2; US9,089,288; US 9,089,288 B2; 9089288; Appl. No. 13/436,991US2...
Provided are systems and methods to temporarily alter visual acuity of a subject. An example system ...
Methods, systems, and ophthalmic devices are described for correcting a misperception of depth of a ...
USRE45147; USRE45,147 E; USRE45147E; USRE 45,147; US RE45147 E; 45,147; Appl. No. 13/662,420US2014-2...
This tool was used to measure refractive error, which occurs when the shape of the eye fails to brin...
A device is used to determine the presence of and the amount (depth) of visual suppression in a subj...
Paraxial rays and marginal rays entering the eye do not share a common point of focus in emmetropes,...
The present invention relates in general to therapeutic compositions and methods of use. In preferre...
Inventor name used in this publication: 谢欣然Inventor name used in this publication: 杜嗣河Inventor name ...
A lens includes a center of the ophthalmic lens having a negative power that provides foveal vision ...
Amblyopia is defined as a decrease in visual acuity that results from abnormal binocular interaction...
US9918894B2; US9918894 B2; US9918894B2; US9,918,894; US9918894 B2; 9918894; Appl. No. 15/009,224US20...
US9829722; US9829722 B2; US9829722B2; US9,829,722; US 9,829,722 B2; 9829722; Appl. No. 14/581,003US2...
US9557099; US9557099 B2; US9557099B2; US9,557,099; US 9,557,099 B2; 9557099; Appl. No. 14/261,868US2...
A method for retarding the progression of myopia in a human eye is provided. The method comprises pr...
US9089288; US9089288 B2; US9089288B2; US9,089,288; US 9,089,288 B2; 9089288; Appl. No. 13/436,991US2...
Provided are systems and methods to temporarily alter visual acuity of a subject. An example system ...
Methods, systems, and ophthalmic devices are described for correcting a misperception of depth of a ...
USRE45147; USRE45,147 E; USRE45147E; USRE 45,147; US RE45147 E; 45,147; Appl. No. 13/662,420US2014-2...
This tool was used to measure refractive error, which occurs when the shape of the eye fails to brin...
A device is used to determine the presence of and the amount (depth) of visual suppression in a subj...
Paraxial rays and marginal rays entering the eye do not share a common point of focus in emmetropes,...
The present invention relates in general to therapeutic compositions and methods of use. In preferre...
Inventor name used in this publication: 谢欣然Inventor name used in this publication: 杜嗣河Inventor name ...
A lens includes a center of the ophthalmic lens having a negative power that provides foveal vision ...
Amblyopia is defined as a decrease in visual acuity that results from abnormal binocular interaction...